These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
452 related items for PubMed ID: 17280747
41. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen. Sallam TA, Raja'a YA, Benbrake MS, Al-Shaibani KS, Al-Hababi AA. East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744 [Abstract] [Full Text] [Related]
42. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P. J Infect Dis; 2003 May 15; 187 Suppl 1():S217-22. PubMed ID: 12721916 [Abstract] [Full Text] [Related]
43. [Determining factors of rubella in the 10 to 14 year-old population in Mexico]. Tapia-Conyer R, Sepúlveda J, Salvatierra B, Muńoz O, Bustamante-Calvillo E, Alvarez y Muńoz T, Gutiérrez G. Salud Publica Mex; 1992 May 15; 34(2):211-21. PubMed ID: 1631734 [Abstract] [Full Text] [Related]
44. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001. Lanzieri TM, Segatto TC, Siqueira MM, de Oliviera Santos EC, Jin L, Prevots DR. Pediatr Infect Dis J; 2003 Apr 15; 22(4):323-9. PubMed ID: 12690271 [Abstract] [Full Text] [Related]
45. Rubella seroprevalence among healthy individuals in Izmir, Turkey. Kurugöl Z, Midyat L, Türkoğlu E, Ozacar T. Hum Vaccin; 2011 Sep 15; 7(9):972-5. PubMed ID: 21860258 [Abstract] [Full Text] [Related]
46. Success and failure of a rubella immunization programme. Swartz TA, Porath EB, Hornstein L. Dev Biol Stand; 1979 Sep 15; 43():355-60. PubMed ID: 520682 [Abstract] [Full Text] [Related]
47. Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns. Lo Giudice D, Cannavò G, Capua A, Grillo OC, La Fauci V, Puliafito A, Sindoni D, Squeri R, Calimeri S. J Prev Med Hyg; 2009 Dec 15; 50(4):236-40. PubMed ID: 20812520 [Abstract] [Full Text] [Related]
48. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data. Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S664-8. PubMed ID: 21954264 [Abstract] [Full Text] [Related]
49. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Bull World Health Organ; 1997 Sep 01; 75(1):55-68. PubMed ID: 9141751 [Abstract] [Full Text] [Related]
50. Prevalence of antibodies to measles and rubella in Sana'a, Yemen. Sallam TA, Al-Jaufy AY, Al-Shaibany KS, Ghauth AB, Best JM. Vaccine; 2006 Sep 11; 24(37-39):6304-8. PubMed ID: 16815602 [Abstract] [Full Text] [Related]
51. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003. Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R. Am J Infect Control; 2006 Nov 11; 34(9):588-92. PubMed ID: 17097454 [Abstract] [Full Text] [Related]
52. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling. Hachiya M, Vynnycky E, Mori Y, Do HT, Huynh MK, Trinh LH, Nguyen DD, Tran NAT, Hoang TT, Hoang HHT, Vo NDT, Le TH, Ichimura Y, Miyano S, Okawa S, Thandar MM, Yokobori Y, Inoue Y, Mizoue T, Takeda M, Komada K. Int J Infect Dis; 2024 Jul 11; 144():107053. PubMed ID: 38641317 [Abstract] [Full Text] [Related]
53. Rubella outbreak on Tokunoshima Island in 2004: serological and epidemiological analysis of pregnant women with rubella. Kaneko M, Sameshima H, Ikenoue T, Minematsu T, Kusumoto K, Ibara S, Kamitomo M, Maruyama Y. J Obstet Gynaecol Res; 2006 Oct 11; 32(5):461-7. PubMed ID: 16984512 [Abstract] [Full Text] [Related]
54. [A study on rubella antibody screening and immunization of women of childbearing age]. Lu BC. Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Feb 11; 9(1):16-8. PubMed ID: 3383230 [No Abstract] [Full Text] [Related]
55. Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in Taiwan. Lin CC, Yang CY, Shih YL, Hsu HW, Yang TH, Cheng YW, Chang CF, Hsieh LC, Chen BH, Lee CH, Huang YL. BJOG; 2011 May 11; 118(6):706-12. PubMed ID: 21385304 [Abstract] [Full Text] [Related]
56. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. Onyenekwe CC, Kehinde-Agbeyangi TA, Ofor US, Arinola OG. West Afr J Med; 2000 May 11; 19(1):23-6. PubMed ID: 10821082 [Abstract] [Full Text] [Related]
57. Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand. Boonruang S, Buppasiri P. J Med Assoc Thai; 2005 Apr 11; 88(4):455-9. PubMed ID: 16146247 [Abstract] [Full Text] [Related]
58. Prevalence of antibodies against rubella virus in Spain. Eiros Bouza JM, Luquero Alcalde FJ, Castrodeza Sanz JJ, Bachiller Luque MR, de Lejarazu Leonardo RO. Clin Infect Dis; 2007 Feb 01; 44(3):465-6. PubMed ID: 17205464 [No Abstract] [Full Text] [Related]
59. Rubella and congenital rubella syndrome in Japan: epidemiological problems. Terada K. Jpn J Infect Dis; 2003 Jun 01; 56(3):81-7. PubMed ID: 12944671 [Abstract] [Full Text] [Related]
60. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains]. Zou J, Senecal J, Morvan A, Roussey A. Ann Pediatr (Paris); 1976 Feb 02; 23(2):111-8. PubMed ID: 16104238 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]